TickerFactsScreenerDevelopers

LakeShore Biopharma Co., Ltd. (LSBCF) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2021: 59.66M CNY2022: 117.07M CNY2023: 153.36M CNY2024: 117.69M CNY2025: 107.77M CNY107.77M CNY
2021Cost of Revenue (CNY)2025
Fiscal YearCost of RevenueChange YoY
2025107.77M CNY-8.4%
2024117.69M CNY-23.3%
2023153.36M CNY+31.0%
2022117.07M CNY+96.2%
202159.66M CNY—